Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.00
Bid: 108.00
Ask: 112.00
Change: 2.50 (2.33%)
Spread: 4.00 (3.704%)
Open: 107.50
High: 111.00
Low: 107.50
Prev. Close: 107.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealings

28 Jul 2021 14:40

RNS Number : 7981G
Eco Animal Health Group PLC
28 July 2021
 

28 July 2021

 

 

ECO Animal Health Group PLC

("ECO" or "the Company")

 

Directors Dealings

 

ECO Animal Health Group plc was notified today that on 28 July 2021 the following Director purchases of ordinary shares of 5p each in the capital of the Company ("Ordinary Shares") were made.

 

Dr Andrew Jones, Non-Executive Chairman of the Company, purchased 7,500 Ordinary Shares at a price of 330 pence per Ordinary Share. As a result of this transaction, Dr Jones' total shareholding in the Company comprises 7,500 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

 

Dr Frank Armstrong, a Non-Executive Director of the Company, purchased 3,000 Ordinary Shares at a price of 324 pence per Ordinary Share. As a result of this transaction, Dr Armstrong's total shareholding in the Company comprises 3,000 Ordinary Shares, representing approximately 0.004 per cent. of the Company's issued share capital.

 

Christopher Wilks, Chief Financial Officer of the Company, purchased 7,500 Ordinary Shares at a price of 330 pence per Ordinary Share. As a result of this transaction, Christopher Wilks' total shareholding in the Company comprises 7,500 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.

For further information please contact:

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 

020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Mark Taylor

Iqra Amin

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

 

 

 

PDMR Notification

The notification below is made in accordance with the requirements of MAR

Acquisition of Ordinary Shares

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Andrew Jones

 

2.

Reason for the notification

a.

Position/status

Non-Executive Chairman

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

330.00p

7,500

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Frank Armstrong

 

2.

Reason for the notification

a.

Position/status

Non-Executive Director

 

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

324.00p

3,000

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Wilks

 

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Eco Animal Health Group Plc

b.

LEI

2138009XN9DJ3YP70B55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each.

 

GB0032036807 

 

b.

Nature of the transaction

Acquisition of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

330.00p

7,500

d.

Aggregated information

Aggregated volume

Price

 

 

 

n/a

 

e.

Date of the transaction

28 July 2021

f.

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADXPAADFEFA
Date   Source Headline
2nd Aug 20191:12 pmBUSCirc re. Posting of Annual Report 2019
1st Aug 20192:17 pmBUSDirector/PDMR Shareholding
1st Aug 20197:00 amBUSBlock listing Interim Review
1st Aug 20197:00 amBUSTotal Voting Rights
8th Jul 20198:23 amBUSHolding(s) in Company
3rd Jul 20197:59 amBUSHolding(s) in Company
19th Jun 20197:00 amBUSFinal Results
5th Jun 201912:43 pmBUSHolding(s) in Company
29th May 20193:13 pmBUSDoc re. Change of Director Responsibilities
2nd Apr 20197:00 amBUSRegulatory Approval
20th Mar 20197:00 amBUSHolding(s) in Company
7th Mar 20197:05 amBUSDirector/PDMR Shareholding
7th Mar 20197:00 amBUSDirectorate change
5th Mar 20197:00 amBUSRegulatory Approval
13th Feb 20197:00 amBUSStatement Re ECO Animal Health and Ghent University Sign Poultry Vaccine Development Licencing Deal
7th Feb 201911:50 amBUSDirector/PDMR Shareholding
5th Feb 20199:58 amBUSHolding(s) in Company
5th Feb 20197:00 amBUSStatement re ECO Animal Health and University of Georgia sign second poultry vaccine development licencing deal
1st Feb 20197:00 amBUSTotal Voting Rights
1st Feb 20197:00 amBUSBlock listing Interim Review
31st Jan 201911:14 amBUSHolding(s) in Company
16th Jan 201910:48 amBUSDirector/PDMR Shareholding
27th Dec 20187:19 amBUSHolding(s) in Company
13th Dec 20183:00 pmBUSHolding(s) in Company
10th Dec 20187:00 amBUSHalf-year Report
5th Dec 201810:31 amBUSHolding(s) in Company
3rd Dec 20187:00 amBUSStatement re ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation development and licencing deal
27th Nov 20189:32 amBUSNotice of Results
19th Nov 20187:00 amBUSStatement re Joint poultry vaccine development licencing deal
7th Nov 20187:00 amBUSRegulatory Approval
1st Nov 20183:40 pmBUSHolding(s) in Company
1st Nov 20183:01 pmBUSHolding(s) in Company
26th Oct 20187:48 amBUSDirector/PDMR Shareholding
16th Oct 201811:26 amBUSHolding(s) in Company
20th Jul 20182:09 pmBUSDirector/PDMR Shareholding
18th Jul 201810:06 amBUSHolding(s) in Company
18th Jul 201810:01 amBUSHolding(s) in Company
10th Jul 20188:58 amBUSHolding(s) in Company
3rd Jul 20189:05 amBUSHolding(s) in Company
3rd Jul 20189:03 amBUSHolding(s) in Company
2nd Jul 20181:16 pmBUSDoc re. Block Listing Admission
2nd Jul 20187:00 amBUSFinal Results
1st May 20188:37 amBUSTotal Voting Rights
24th Apr 201811:22 amBUSHolding(s) in Company
12th Apr 201810:16 amBUSDirector/PDMR Shareholding
11th Apr 201812:03 pmBUSDirector/PDMR Shareholding
5th Apr 201812:02 pmBUSDirector/PDMR Shareholding - Replacement
5th Apr 201810:44 amBUSDirector/PDMR Shareholding
3rd Apr 20187:00 amBUSJoint Venture
5th Mar 20187:00 amBUSRegulatory Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.